Nano-X Imaging (NNOX) said: “The Company’s current revenue base remains at an early stage, and the timing and pace of revenue growth are expected to depend primarily on the timing of system activations, the transition of installed systems into revenue-generating operations, and the impact of deployments carried out by the Company’s business partners. As additional systems become operational and utilization increases, the Company expects revenue to grow over time. However, the timing and magnitude of such growth may vary and are subject to a number of factors, including deployment progress, regulatory approvals, and other factors beyond the Company’s control.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano-X Imaging announces commercial agreement with Howard Technology
- Nano-X Imaging Posts Wider Q4 Loss but Accelerates U.S. Rollout and CFO Transition
- Options Volatility and Implied Earnings Moves Today, April 20, 2026
- Nano-X Imaging announces clinical collaboration with Meir Medical Center
- Nano-X Imaging subsidiary signs distribution pact with Digital X-Ray Imaging
